Cargando…
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT
Availability of haploidentical donors has broadened utilization of allogeneic hematopoietic cell transplantation (allo-HCT). Peripheral blood stem cells (PBSC) are being used with increased frequency in haploidentical allo-HCT. We evaluated extent of HLA disparity (2–3/8 versus 4/8 HLA antigen misma...
Autores principales: | Kharfan-Dabaja, Mohamed A., Labopin, Myriam, Ayala, Ernesto, Bazarbachi, Ali, Blaise, Didier, Vydra, Jan, Bramanti, Stefania, Itälä-Remes, Maija, Schmid, Christoph, Busca, Alessandro, Forcade, Edouard, Rabitsch, Werner, Zecca, Marco, Kröger, Nicolaus, Bulabois, Claude-Eric, Grillo, Giovanni, Rambaldi, Alessandro, Fanin, Renato, Zallio, Francesco, Di Renzo, Nicola, Koc, Yener, Novis, Yana, McDonald, Andrew, Herrera Arroyo, Concepcion, Sanz, Jaime, Nagler, Arnon, Ciceri, Fabio, Mohty, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306430/ https://www.ncbi.nlm.nih.gov/pubmed/37388926 http://dx.doi.org/10.1097/HS9.0000000000000920 |
Ejemplares similares
-
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT
por: Rubio, Marie T., et al.
Publicado: (2016) -
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2023) -
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
por: Ruggeri, Annalisa, et al.
Publicado: (2018) -
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
por: Nagler, Arnon, et al.
Publicado: (2023) -
Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
por: Nagler, Arnon, et al.
Publicado: (2023)